Next Article in Journal
Possibilities of Overcoming Resistance to Osimertinib in NSCLC Patients with Mutations in the EGFR Gene
Next Article in Special Issue
Adjuvant Therapy in “Intermediate-Risk” Early-Stage Cervical Cancer: To Treat or Not to Treat? Systematic Review and Meta-Analysis
Previous Article in Journal
Exploring the Potential of Adjuvant CDK4/6 Inhibitors in Hormone Receptor-Positive Early Breast Cancer: A Consistent Approach for All
Previous Article in Special Issue
Unveiling Prostate-Specific Membrane Antigen’s Potential in Breast Cancer Management
 
 
Article

Article Versions Notes

Cancers 2025, 17(4), 562; https://doi.org/10.3390/cancers17040562
Action Date Notes Link
article xml file uploaded 7 February 2025 06:56 CET Original file -
article xml uploaded. 7 February 2025 06:56 CET Update https://www.mdpi.com/2072-6694/17/4/562/xml
article pdf uploaded. 7 February 2025 06:56 CET Version of Record https://www.mdpi.com/2072-6694/17/4/562/pdf
article html file updated 7 February 2025 06:57 CET Original file -
article html file updated 24 June 2025 15:27 CEST Update https://www.mdpi.com/2072-6694/17/4/562/html
Back to TopTop